Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
61 /100
HIGH RISK
Score updated Oct 27, 2026

DTIL — Precision BioSciences, Inc. Dilution Risk Tracker

Track DTIL dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DTIL — Get alerts when the score changes →

As of October 27, 2026, Precision BioSciences, Inc. (DTIL) has a DilutionWatch DilutionScore of 61/100, rated HIGH dilution risk. Precision BioSciences, Inc. has a market capitalization of $176.93M, 27.60M shares outstanding, 78 institutional holders tracked. Stored dilution-related fields include 8.61M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
40
📊 Float Risk
45
⚠️ Warrant Exposure
70
🔄 Convertible Debt
60

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 39%
📜 Warrant Exercise model 50%
• Massive warrant overhang: 31% of shares outstanding
• Elevated warrant risk score (70/100)
🔁 Convertible Conversion model 40%
• Significant convertible debt: 22% potential dilution
• Elevated convertible risk (60/100)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (61/100)
🔔 Track DTIL — Get forecast alerts →

Market Data

Market Cap$176.93M
Shares Outstanding27.60M
Float20.01M
Cash$87.55M
Debt$22.27M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore61/100DilutionWatch score record
Shares Outstanding27.60MVerified float table or market cache
Public Float20.01MVerified float table or market cache
Market Cap$176.93MMarket data cache
Cash Runway12.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants8.61MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 5, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

DTIL SEC Filing Activity — Last 12 Months

Shares outstanding reported by DTIL on the cover page of its latest 10-K/10-Q: 27.60M as of August 03, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for DTIL in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)9Aug 24, 2026
10-Kannual report1Mar 12, 2026
10-Qquarterly report2Aug 06, 2026
DEF 14Aproxy statement1Apr 08, 2026
3initial insider ownership24Sep 30, 2026

Institutional Holdings

QoQ: ↑ 14.0% shares (2026Q1 vs prior)
78 institutional holders · 17.22M shares
#1 Octagon Capital Advisors LP 2.24M shares
#2 Aberdeen Group plc 2.23M shares
#3 Empery Asset Management, LP 1.97M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.36M
Days to Cover9.3
% of Float11.8%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-12
xbrl XBRL CONVERTIBLE 2021-03-18
4 INSIDER TRANSACTION 2026-06-05
4 INSIDER TRANSACTION 2026-06-05
4 INSIDER TRANSACTION 2026-06-05
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual DTIL Dilution Snapshot

Precision BioSciences, Inc. (DTIL) has a DilutionScore of 61/100, rated High dilution risk. Score date: October 27, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

DTIL's DilutionScore is currently 61/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 56/100 (High risk).

Period Score Risk Level Duration
Sep 28 – Oct 27, 202661/100HIGH30 days
Aug 22 – Sep 27, 202656/100HIGH37 days
Aug 14 – Aug 21, 202652/100HIGH7 days
Jul 30 – Aug 13, 202656/100HIGH15 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

DTIL shares outstanding have increased 7.2% from 24.07M (Mar 2026) to 25.80M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 24, 202625.80M20.01M▼ 0.52%
May 18, 202625.81M20.11M▼ 1.56%
May 17, 202625.81M20.43M▲ 4.35%
Apr 18, 202625.80M19.58M▲ 1.12%
Apr 01, 202624.73M19.36M▲ 1.22%
Mar 17, 202624.73M19.13M▲ 0.80%
Mar 14, 202624.07M18.98M▲ 86.52%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track DTIL Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment DTIL files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking DTIL — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,566+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DTIL
DTIL FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.